GMP Unit UZ Gent
Advanced Therapies and Clinical-Grade Production at CellGENTherapies
Mission
At CellGENTherapies, we specialize in the production of advanced gene-, cell-, and tissue-therapeutic products (ATMPs) for early phase clinical trials.
Their mission is to bring research “from bench to bedside” by offering academic and industry partners small-scale production of RNA vaccines and ATMPs, particularly for personalized medicine and Phase I studies, in accordance with Good Manufacturing Practices (GMP).
About the GMP Unit
Established in 2014, CellGEN Therapies has grown to become a licensed producer of investigational ATMPs. In 2016, it produced its first ATMP under GMP conditions, and the portfolio has since expanded to include new technologies.
In 2024, CellGEN plans to secure licensing for microbial vaccine production. To meet increasing demand, a new GMP facility will be operational by mid-2025 on the Ghent University Hospital campus, creating synergy between academic research, clinical expertise, and biotech innovation.
- GMP Unit Website
- UZ Gent campus, entrance 71, route 724 Corneel Heymanslaan 10, 9000 Gent, Belgium
- ti.desmet@ugent.be
NanoMedicine Centre
Ghent Research Group on Nanomedicines
Pioneering Nanomedicine for Advanced Therapeutic Delivery
Core ARTH Animal Facilities
Animal Facilities
Advancing preclinical, biomedical and laboratory animal research
